// company-profile

Dianthus Therapeutics, Inc. /DE/

DNTH
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings74Insiders21
// api This Dianthus Therapeutics, Inc. /DE/ insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).

// 90-day insight

Over the last 90 days, Dianthus Therapeutics, Inc. /DE/ insiders bought $0 across 7 transactions with no open-market sales.

  • Most active insider: Savitz Ryan with 15 transactions totaling $11.7M.
  • Largest single sale: $5.0M by Savitz Ryan on Mar 31, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Dianthus Therapeutics, Inc. /DE/ as of 2026-03-31

↑ increasing
Total reported AUM
$4.91B
QoQ change
+156.6%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$469.1M
5.6M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$219.2M
2.6M shares
#3
Fairmount Funds Management LLC
CIK 1802528
$212.9M
2.5M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Veness Adam MDNTH
Sale10b5
13,229$81.38$1.08M
Jun 17, 2026Veness Adam MDNTH
Option Exercise10b5
30,000$0.00$0K
Jun 17, 2026Veness Adam MDNTH
Option Exercise10b5
30,000$17.88$536K
Jun 17, 2026Veness Adam MDNTH
Sale10b5
16,771$80.34$1.35M
Jun 1, 2026Randhawa SimratDNTH
Option Exercise10b5
9,375$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.